nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethadione—CYP2C8—Paclitaxel—ovarian cancer	0.115	0.249	CbGbCtD
Trimethadione—CYP3A4—Topotecan—ovarian cancer	0.0945	0.204	CbGbCtD
Trimethadione—CYP2C9—Paclitaxel—ovarian cancer	0.0805	0.174	CbGbCtD
Trimethadione—CYP3A4—Vinorelbine—ovarian cancer	0.0666	0.144	CbGbCtD
Trimethadione—CYP3A4—Paclitaxel—ovarian cancer	0.0468	0.101	CbGbCtD
Trimethadione—CYP3A4—Docetaxel—ovarian cancer	0.0338	0.0731	CbGbCtD
Trimethadione—CYP3A4—Doxorubicin—ovarian cancer	0.0252	0.0545	CbGbCtD
Trimethadione—Non-Hodgkin's lymphoma—Melphalan—ovarian cancer	0.0176	0.0328	CcSEcCtD
Trimethadione—Lymphoma—Melphalan—ovarian cancer	0.0176	0.0328	CcSEcCtD
Trimethadione—Nephrotic syndrome—Chlorambucil—ovarian cancer	0.0146	0.0272	CcSEcCtD
Trimethadione—Tonic-clonic seizures—Paclitaxel—ovarian cancer	0.0134	0.025	CcSEcCtD
Trimethadione—Hepatosplenomegaly—Epirubicin—ovarian cancer	0.0126	0.0234	CcSEcCtD
Trimethadione—Pancytopenia—Altretamine—ovarian cancer	0.0118	0.022	CcSEcCtD
Trimethadione—Hepatosplenomegaly—Doxorubicin—ovarian cancer	0.0116	0.0217	CcSEcCtD
Trimethadione—Lupus erythematosus—Docetaxel—ovarian cancer	0.0082	0.0153	CcSEcCtD
Trimethadione—Vertigo—Altretamine—ovarian cancer	0.00778	0.0145	CcSEcCtD
Trimethadione—Leukopenia—Altretamine—ovarian cancer	0.00775	0.0145	CcSEcCtD
Trimethadione—Grand mal convulsion—Paclitaxel—ovarian cancer	0.00757	0.0141	CcSEcCtD
Trimethadione—Thrombocytopenia—Altretamine—ovarian cancer	0.00692	0.0129	CcSEcCtD
Trimethadione—Anorexia—Altretamine—ovarian cancer	0.00673	0.0126	CcSEcCtD
Trimethadione—Systemic lupus erythematosus—Paclitaxel—ovarian cancer	0.00651	0.0122	CcSEcCtD
Trimethadione—Decreased appetite—Altretamine—ovarian cancer	0.00614	0.0115	CcSEcCtD
Trimethadione—Fatigue—Altretamine—ovarian cancer	0.00609	0.0114	CcSEcCtD
Trimethadione—Lymphadenopathy—Chlorambucil—ovarian cancer	0.00599	0.0112	CcSEcCtD
Trimethadione—Systemic lupus erythematosus—Docetaxel—ovarian cancer	0.00552	0.0103	CcSEcCtD
Trimethadione—Asthenia—Altretamine—ovarian cancer	0.00507	0.00947	CcSEcCtD
Trimethadione—Aplastic anaemia—Vinorelbine—ovarian cancer	0.00503	0.0094	CcSEcCtD
Trimethadione—Vomiting—Altretamine—ovarian cancer	0.00449	0.00839	CcSEcCtD
Trimethadione—Nausea—Altretamine—ovarian cancer	0.0042	0.00784	CcSEcCtD
Trimethadione—Pancytopenia—Chlorambucil—ovarian cancer	0.00419	0.00783	CcSEcCtD
Trimethadione—Neutropenia—Chlorambucil—ovarian cancer	0.00413	0.00771	CcSEcCtD
Trimethadione—Pancytopenia—Topotecan—ovarian cancer	0.00373	0.00697	CcSEcCtD
Trimethadione—Neutropenia—Topotecan—ovarian cancer	0.00367	0.00686	CcSEcCtD
Trimethadione—Pancytopenia—Melphalan—ovarian cancer	0.00365	0.00683	CcSEcCtD
Trimethadione—Gingival bleeding—Epirubicin—ovarian cancer	0.00363	0.00678	CcSEcCtD
Trimethadione—Neutropenia—Melphalan—ovarian cancer	0.0036	0.00672	CcSEcCtD
Trimethadione—Gingival bleeding—Doxorubicin—ovarian cancer	0.00336	0.00628	CcSEcCtD
Trimethadione—Erythema multiforme—Chlorambucil—ovarian cancer	0.00334	0.00624	CcSEcCtD
Trimethadione—Epistaxis—Topotecan—ovarian cancer	0.0033	0.00617	CcSEcCtD
Trimethadione—Pancytopenia—Vinorelbine—ovarian cancer	0.00319	0.00596	CcSEcCtD
Trimethadione—Haemoglobin—Topotecan—ovarian cancer	0.00316	0.0059	CcSEcCtD
Trimethadione—Haemorrhage—Topotecan—ovarian cancer	0.00315	0.00588	CcSEcCtD
Trimethadione—Neutropenia—Vinorelbine—ovarian cancer	0.00314	0.00587	CcSEcCtD
Trimethadione—Alopecia—Chlorambucil—ovarian cancer	0.00312	0.00583	CcSEcCtD
Trimethadione—Haemoglobin—Melphalan—ovarian cancer	0.0031	0.00578	CcSEcCtD
Trimethadione—Haemorrhage—Melphalan—ovarian cancer	0.00308	0.00575	CcSEcCtD
Trimethadione—Hepatitis—Melphalan—ovarian cancer	0.00308	0.00575	CcSEcCtD
Trimethadione—Weight decreased—Vinorelbine—ovarian cancer	0.00304	0.00568	CcSEcCtD
Trimethadione—Agranulocytosis—Vinorelbine—ovarian cancer	0.0028	0.00522	CcSEcCtD
Trimethadione—Vaginal haemorrhage—Epirubicin—ovarian cancer	0.00278	0.0052	CcSEcCtD
Trimethadione—Alopecia—Topotecan—ovarian cancer	0.00278	0.00519	CcSEcCtD
Trimethadione—Dermatitis exfoliative—Paclitaxel—ovarian cancer	0.00277	0.00518	CcSEcCtD
Trimethadione—Albuminuria—Epirubicin—ovarian cancer	0.00276	0.00515	CcSEcCtD
Trimethadione—Leukopenia—Chlorambucil—ovarian cancer	0.00275	0.00514	CcSEcCtD
Trimethadione—Alopecia—Melphalan—ovarian cancer	0.00272	0.00508	CcSEcCtD
Trimethadione—Vaginal haemorrhage—Doxorubicin—ovarian cancer	0.00258	0.00481	CcSEcCtD
Trimethadione—Albuminuria—Doxorubicin—ovarian cancer	0.00255	0.00477	CcSEcCtD
Trimethadione—Ill-defined disorder—Topotecan—ovarian cancer	0.00254	0.00475	CcSEcCtD
Trimethadione—Malaise—Topotecan—ovarian cancer	0.00247	0.00461	CcSEcCtD
Trimethadione—Thrombocytopenia—Chlorambucil—ovarian cancer	0.00246	0.00459	CcSEcCtD
Trimethadione—Leukopenia—Topotecan—ovarian cancer	0.00245	0.00458	CcSEcCtD
Trimethadione—Leukopenia—Melphalan—ovarian cancer	0.0024	0.00448	CcSEcCtD
Trimethadione—Anorexia—Chlorambucil—ovarian cancer	0.00239	0.00447	CcSEcCtD
Trimethadione—Alopecia—Vinorelbine—ovarian cancer	0.00238	0.00444	CcSEcCtD
Trimethadione—Discomfort—Topotecan—ovarian cancer	0.0023	0.0043	CcSEcCtD
Trimethadione—Thrombocytopenia—Topotecan—ovarian cancer	0.00219	0.00409	CcSEcCtD
Trimethadione—Decreased appetite—Chlorambucil—ovarian cancer	0.00218	0.00408	CcSEcCtD
Trimethadione—Ill-defined disorder—Vinorelbine—ovarian cancer	0.00217	0.00406	CcSEcCtD
Trimethadione—Fatigue—Chlorambucil—ovarian cancer	0.00216	0.00404	CcSEcCtD
Trimethadione—Pancytopenia—Paclitaxel—ovarian cancer	0.00215	0.00401	CcSEcCtD
Trimethadione—Thrombocytopenia—Melphalan—ovarian cancer	0.00214	0.004	CcSEcCtD
Trimethadione—Anorexia—Topotecan—ovarian cancer	0.00213	0.00398	CcSEcCtD
Trimethadione—Neutropenia—Paclitaxel—ovarian cancer	0.00211	0.00395	CcSEcCtD
Trimethadione—Malaise—Vinorelbine—ovarian cancer	0.00211	0.00395	CcSEcCtD
Trimethadione—Vertigo—Vinorelbine—ovarian cancer	0.0021	0.00393	CcSEcCtD
Trimethadione—Leukopenia—Vinorelbine—ovarian cancer	0.0021	0.00392	CcSEcCtD
Trimethadione—Anorexia—Melphalan—ovarian cancer	0.00209	0.0039	CcSEcCtD
Trimethadione—Feeling abnormal—Chlorambucil—ovarian cancer	0.00207	0.00386	CcSEcCtD
Trimethadione—Hiccups—Epirubicin—ovarian cancer	0.00206	0.00385	CcSEcCtD
Trimethadione—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00205	0.00383	CcSEcCtD
Trimethadione—Weight decreased—Paclitaxel—ovarian cancer	0.00205	0.00382	CcSEcCtD
Trimethadione—Paraesthesia—Topotecan—ovarian cancer	0.00201	0.00375	CcSEcCtD
Trimethadione—Abdominal pain—Chlorambucil—ovarian cancer	0.00198	0.00371	CcSEcCtD
Trimethadione—Discomfort—Vinorelbine—ovarian cancer	0.00197	0.00368	CcSEcCtD
Trimethadione—Paraesthesia—Melphalan—ovarian cancer	0.00196	0.00367	CcSEcCtD
Trimethadione—Decreased appetite—Topotecan—ovarian cancer	0.00194	0.00363	CcSEcCtD
Trimethadione—Aplastic anaemia—Epirubicin—ovarian cancer	0.00193	0.00361	CcSEcCtD
Trimethadione—Fatigue—Topotecan—ovarian cancer	0.00193	0.0036	CcSEcCtD
Trimethadione—Hiccups—Doxorubicin—ovarian cancer	0.00191	0.00356	CcSEcCtD
Trimethadione—Decreased appetite—Melphalan—ovarian cancer	0.0019	0.00355	CcSEcCtD
Trimethadione—Epistaxis—Paclitaxel—ovarian cancer	0.0019	0.00355	CcSEcCtD
Trimethadione—Fatigue—Melphalan—ovarian cancer	0.00189	0.00352	CcSEcCtD
Trimethadione—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00187	0.0035	CcSEcCtD
Trimethadione—Feeling abnormal—Topotecan—ovarian cancer	0.00184	0.00344	CcSEcCtD
Trimethadione—Gastrointestinal pain—Topotecan—ovarian cancer	0.00183	0.00341	CcSEcCtD
Trimethadione—Anorexia—Vinorelbine—ovarian cancer	0.00182	0.0034	CcSEcCtD
Trimethadione—Pancytopenia—Docetaxel—ovarian cancer	0.00182	0.0034	CcSEcCtD
Trimethadione—Haemoglobin—Paclitaxel—ovarian cancer	0.00182	0.0034	CcSEcCtD
Trimethadione—Haemorrhage—Paclitaxel—ovarian cancer	0.00181	0.00338	CcSEcCtD
Trimethadione—Asthenia—Chlorambucil—ovarian cancer	0.0018	0.00336	CcSEcCtD
Trimethadione—Neutropenia—Docetaxel—ovarian cancer	0.00179	0.00335	CcSEcCtD
Trimethadione—Aplastic anaemia—Doxorubicin—ovarian cancer	0.00179	0.00334	CcSEcCtD
Trimethadione—Pruritus—Chlorambucil—ovarian cancer	0.00178	0.00332	CcSEcCtD
Trimethadione—Abdominal pain—Topotecan—ovarian cancer	0.00177	0.0033	CcSEcCtD
Trimethadione—Lymphadenopathy—Epirubicin—ovarian cancer	0.00175	0.00327	CcSEcCtD
Trimethadione—Weight decreased—Docetaxel—ovarian cancer	0.00173	0.00324	CcSEcCtD
Trimethadione—Paraesthesia—Vinorelbine—ovarian cancer	0.00172	0.00321	CcSEcCtD
Trimethadione—Erythema multiforme—Paclitaxel—ovarian cancer	0.00171	0.0032	CcSEcCtD
Trimethadione—Decreased appetite—Vinorelbine—ovarian cancer	0.00166	0.0031	CcSEcCtD
Trimethadione—Fatigue—Vinorelbine—ovarian cancer	0.00165	0.00308	CcSEcCtD
Trimethadione—Lymphadenopathy—Doxorubicin—ovarian cancer	0.00162	0.00303	CcSEcCtD
Trimethadione—Epistaxis—Docetaxel—ovarian cancer	0.00161	0.00301	CcSEcCtD
Trimethadione—Asthenia—Topotecan—ovarian cancer	0.0016	0.00299	CcSEcCtD
Trimethadione—Alopecia—Paclitaxel—ovarian cancer	0.0016	0.00299	CcSEcCtD
Trimethadione—Vomiting—Chlorambucil—ovarian cancer	0.0016	0.00298	CcSEcCtD
Trimethadione—Agranulocytosis—Docetaxel—ovarian cancer	0.00159	0.00298	CcSEcCtD
Trimethadione—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.00158	0.00296	CcSEcCtD
Trimethadione—Pruritus—Topotecan—ovarian cancer	0.00158	0.00295	CcSEcCtD
Trimethadione—Feeling abnormal—Vinorelbine—ovarian cancer	0.00158	0.00294	CcSEcCtD
Trimethadione—Asthenia—Melphalan—ovarian cancer	0.00157	0.00293	CcSEcCtD
Trimethadione—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00156	0.00292	CcSEcCtD
Trimethadione—Pruritus—Melphalan—ovarian cancer	0.00155	0.00289	CcSEcCtD
Trimethadione—Haemoglobin—Docetaxel—ovarian cancer	0.00154	0.00288	CcSEcCtD
Trimethadione—Haemorrhage—Docetaxel—ovarian cancer	0.00153	0.00287	CcSEcCtD
Trimethadione—Hepatitis—Docetaxel—ovarian cancer	0.00153	0.00287	CcSEcCtD
Trimethadione—Abdominal pain—Vinorelbine—ovarian cancer	0.00151	0.00282	CcSEcCtD
Trimethadione—Diplopia—Epirubicin—ovarian cancer	0.0015	0.00279	CcSEcCtD
Trimethadione—Nausea—Chlorambucil—ovarian cancer	0.00149	0.00279	CcSEcCtD
Trimethadione—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.00147	0.00274	CcSEcCtD
Trimethadione—Ill-defined disorder—Paclitaxel—ovarian cancer	0.00146	0.00273	CcSEcCtD
Trimethadione—Erythema multiforme—Docetaxel—ovarian cancer	0.00145	0.00271	CcSEcCtD
Trimethadione—Vomiting—Topotecan—ovarian cancer	0.00142	0.00265	CcSEcCtD
Trimethadione—Malaise—Paclitaxel—ovarian cancer	0.00142	0.00265	CcSEcCtD
Trimethadione—Vertigo—Paclitaxel—ovarian cancer	0.00142	0.00264	CcSEcCtD
Trimethadione—Leukopenia—Paclitaxel—ovarian cancer	0.00141	0.00263	CcSEcCtD
Trimethadione—Rash—Topotecan—ovarian cancer	0.00141	0.00263	CcSEcCtD
Trimethadione—Dermatitis—Topotecan—ovarian cancer	0.00141	0.00263	CcSEcCtD
Trimethadione—Headache—Topotecan—ovarian cancer	0.0014	0.00261	CcSEcCtD
Trimethadione—Vomiting—Melphalan—ovarian cancer	0.00139	0.0026	CcSEcCtD
Trimethadione—Diplopia—Doxorubicin—ovarian cancer	0.00138	0.00258	CcSEcCtD
Trimethadione—Rash—Melphalan—ovarian cancer	0.00138	0.00258	CcSEcCtD
Trimethadione—Dermatitis—Melphalan—ovarian cancer	0.00138	0.00257	CcSEcCtD
Trimethadione—Asthenia—Vinorelbine—ovarian cancer	0.00137	0.00256	CcSEcCtD
Trimethadione—Alopecia—Docetaxel—ovarian cancer	0.00136	0.00253	CcSEcCtD
Trimethadione—Pruritus—Vinorelbine—ovarian cancer	0.00135	0.00253	CcSEcCtD
Trimethadione—Nausea—Topotecan—ovarian cancer	0.00133	0.00248	CcSEcCtD
Trimethadione—Discomfort—Paclitaxel—ovarian cancer	0.00133	0.00248	CcSEcCtD
Trimethadione—Nausea—Melphalan—ovarian cancer	0.0013	0.00243	CcSEcCtD
Trimethadione—Eosinophilia—Epirubicin—ovarian cancer	0.00128	0.00239	CcSEcCtD
Trimethadione—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00126	0.00235	CcSEcCtD
Trimethadione—Pancytopenia—Epirubicin—ovarian cancer	0.00123	0.00229	CcSEcCtD
Trimethadione—Anorexia—Paclitaxel—ovarian cancer	0.00123	0.00229	CcSEcCtD
Trimethadione—Vomiting—Vinorelbine—ovarian cancer	0.00122	0.00227	CcSEcCtD
Trimethadione—Neutropenia—Epirubicin—ovarian cancer	0.00121	0.00226	CcSEcCtD
Trimethadione—Rash—Vinorelbine—ovarian cancer	0.00121	0.00225	CcSEcCtD
Trimethadione—Dermatitis—Vinorelbine—ovarian cancer	0.0012	0.00225	CcSEcCtD
Trimethadione—Headache—Vinorelbine—ovarian cancer	0.0012	0.00224	CcSEcCtD
Trimethadione—Leukopenia—Docetaxel—ovarian cancer	0.0012	0.00223	CcSEcCtD
Trimethadione—Eosinophilia—Doxorubicin—ovarian cancer	0.00118	0.00221	CcSEcCtD
Trimethadione—Weight decreased—Epirubicin—ovarian cancer	0.00117	0.00218	CcSEcCtD
Trimethadione—Insomnia—Paclitaxel—ovarian cancer	0.00116	0.00217	CcSEcCtD
Trimethadione—Paraesthesia—Paclitaxel—ovarian cancer	0.00115	0.00216	CcSEcCtD
Trimethadione—Drowsiness—Epirubicin—ovarian cancer	0.00115	0.00215	CcSEcCtD
Trimethadione—Somnolence—Paclitaxel—ovarian cancer	0.00114	0.00214	CcSEcCtD
Trimethadione—Pancytopenia—Doxorubicin—ovarian cancer	0.00114	0.00212	CcSEcCtD
Trimethadione—Nausea—Vinorelbine—ovarian cancer	0.00114	0.00212	CcSEcCtD
Trimethadione—Neutropenia—Doxorubicin—ovarian cancer	0.00112	0.00209	CcSEcCtD
Trimethadione—Decreased appetite—Paclitaxel—ovarian cancer	0.00112	0.00209	CcSEcCtD
Trimethadione—Fatigue—Paclitaxel—ovarian cancer	0.00111	0.00207	CcSEcCtD
Trimethadione—Epistaxis—Epirubicin—ovarian cancer	0.00109	0.00203	CcSEcCtD
Trimethadione—Weight decreased—Doxorubicin—ovarian cancer	0.00108	0.00202	CcSEcCtD
Trimethadione—Agranulocytosis—Epirubicin—ovarian cancer	0.00108	0.00201	CcSEcCtD
Trimethadione—Thrombocytopenia—Docetaxel—ovarian cancer	0.00107	0.00199	CcSEcCtD
Trimethadione—Drowsiness—Doxorubicin—ovarian cancer	0.00107	0.00199	CcSEcCtD
Trimethadione—Feeling abnormal—Paclitaxel—ovarian cancer	0.00106	0.00198	CcSEcCtD
Trimethadione—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00105	0.00196	CcSEcCtD
Trimethadione—Haemoglobin—Epirubicin—ovarian cancer	0.00104	0.00194	CcSEcCtD
Trimethadione—Anorexia—Docetaxel—ovarian cancer	0.00104	0.00194	CcSEcCtD
Trimethadione—Hepatitis—Epirubicin—ovarian cancer	0.00103	0.00193	CcSEcCtD
Trimethadione—Haemorrhage—Epirubicin—ovarian cancer	0.00103	0.00193	CcSEcCtD
Trimethadione—Abdominal pain—Paclitaxel—ovarian cancer	0.00102	0.0019	CcSEcCtD
Trimethadione—Epistaxis—Doxorubicin—ovarian cancer	0.00101	0.00188	CcSEcCtD
Trimethadione—Agranulocytosis—Doxorubicin—ovarian cancer	0.000995	0.00186	CcSEcCtD
Trimethadione—Insomnia—Docetaxel—ovarian cancer	0.000986	0.00184	CcSEcCtD
Trimethadione—Paraesthesia—Docetaxel—ovarian cancer	0.000979	0.00183	CcSEcCtD
Trimethadione—Erythema multiforme—Epirubicin—ovarian cancer	0.000978	0.00183	CcSEcCtD
Trimethadione—Somnolence—Docetaxel—ovarian cancer	0.000969	0.00181	CcSEcCtD
Trimethadione—Haemoglobin—Doxorubicin—ovarian cancer	0.000962	0.0018	CcSEcCtD
Trimethadione—Haemorrhage—Doxorubicin—ovarian cancer	0.000957	0.00179	CcSEcCtD
Trimethadione—Hepatitis—Doxorubicin—ovarian cancer	0.000957	0.00179	CcSEcCtD
Trimethadione—Decreased appetite—Docetaxel—ovarian cancer	0.000947	0.00177	CcSEcCtD
Trimethadione—Fatigue—Docetaxel—ovarian cancer	0.00094	0.00176	CcSEcCtD
Trimethadione—Asthenia—Paclitaxel—ovarian cancer	0.000922	0.00172	CcSEcCtD
Trimethadione—Alopecia—Epirubicin—ovarian cancer	0.000914	0.00171	CcSEcCtD
Trimethadione—Pruritus—Paclitaxel—ovarian cancer	0.00091	0.0017	CcSEcCtD
Trimethadione—Erythema multiforme—Doxorubicin—ovarian cancer	0.000905	0.00169	CcSEcCtD
Trimethadione—Feeling abnormal—Docetaxel—ovarian cancer	0.000898	0.00168	CcSEcCtD
Trimethadione—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000891	0.00166	CcSEcCtD
Trimethadione—Abdominal pain—Docetaxel—ovarian cancer	0.000862	0.00161	CcSEcCtD
Trimethadione—Alopecia—Doxorubicin—ovarian cancer	0.000846	0.00158	CcSEcCtD
Trimethadione—Ill-defined disorder—Epirubicin—ovarian cancer	0.000836	0.00156	CcSEcCtD
Trimethadione—Vomiting—Paclitaxel—ovarian cancer	0.000817	0.00153	CcSEcCtD
Trimethadione—Malaise—Epirubicin—ovarian cancer	0.000812	0.00152	CcSEcCtD
Trimethadione—Rash—Paclitaxel—ovarian cancer	0.000811	0.00151	CcSEcCtD
Trimethadione—Dermatitis—Paclitaxel—ovarian cancer	0.00081	0.00151	CcSEcCtD
Trimethadione—Vertigo—Epirubicin—ovarian cancer	0.000809	0.00151	CcSEcCtD
Trimethadione—Leukopenia—Epirubicin—ovarian cancer	0.000806	0.00151	CcSEcCtD
Trimethadione—Headache—Paclitaxel—ovarian cancer	0.000805	0.0015	CcSEcCtD
Trimethadione—Asthenia—Docetaxel—ovarian cancer	0.000782	0.00146	CcSEcCtD
Trimethadione—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000773	0.00144	CcSEcCtD
Trimethadione—Pruritus—Docetaxel—ovarian cancer	0.000771	0.00144	CcSEcCtD
Trimethadione—Nausea—Paclitaxel—ovarian cancer	0.000764	0.00143	CcSEcCtD
Trimethadione—Discomfort—Epirubicin—ovarian cancer	0.000758	0.00142	CcSEcCtD
Trimethadione—Malaise—Doxorubicin—ovarian cancer	0.000752	0.0014	CcSEcCtD
Trimethadione—Vertigo—Doxorubicin—ovarian cancer	0.000749	0.0014	CcSEcCtD
Trimethadione—Leukopenia—Doxorubicin—ovarian cancer	0.000746	0.00139	CcSEcCtD
Trimethadione—Thrombocytopenia—Epirubicin—ovarian cancer	0.00072	0.00134	CcSEcCtD
Trimethadione—Discomfort—Doxorubicin—ovarian cancer	0.000701	0.00131	CcSEcCtD
Trimethadione—Anorexia—Epirubicin—ovarian cancer	0.000701	0.00131	CcSEcCtD
Trimethadione—Vomiting—Docetaxel—ovarian cancer	0.000693	0.00129	CcSEcCtD
Trimethadione—Rash—Docetaxel—ovarian cancer	0.000687	0.00128	CcSEcCtD
Trimethadione—Dermatitis—Docetaxel—ovarian cancer	0.000687	0.00128	CcSEcCtD
Trimethadione—Headache—Docetaxel—ovarian cancer	0.000683	0.00128	CcSEcCtD
Trimethadione—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000666	0.00124	CcSEcCtD
Trimethadione—Insomnia—Epirubicin—ovarian cancer	0.000665	0.00124	CcSEcCtD
Trimethadione—Paraesthesia—Epirubicin—ovarian cancer	0.00066	0.00123	CcSEcCtD
Trimethadione—Somnolence—Epirubicin—ovarian cancer	0.000653	0.00122	CcSEcCtD
Trimethadione—Anorexia—Doxorubicin—ovarian cancer	0.000648	0.00121	CcSEcCtD
Trimethadione—Nausea—Docetaxel—ovarian cancer	0.000647	0.00121	CcSEcCtD
Trimethadione—Decreased appetite—Epirubicin—ovarian cancer	0.000639	0.00119	CcSEcCtD
Trimethadione—Fatigue—Epirubicin—ovarian cancer	0.000634	0.00118	CcSEcCtD
Trimethadione—Insomnia—Doxorubicin—ovarian cancer	0.000615	0.00115	CcSEcCtD
Trimethadione—Paraesthesia—Doxorubicin—ovarian cancer	0.000611	0.00114	CcSEcCtD
Trimethadione—Feeling abnormal—Epirubicin—ovarian cancer	0.000606	0.00113	CcSEcCtD
Trimethadione—Somnolence—Doxorubicin—ovarian cancer	0.000605	0.00113	CcSEcCtD
Trimethadione—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000601	0.00112	CcSEcCtD
Trimethadione—Decreased appetite—Doxorubicin—ovarian cancer	0.000591	0.0011	CcSEcCtD
Trimethadione—Fatigue—Doxorubicin—ovarian cancer	0.000586	0.0011	CcSEcCtD
Trimethadione—Abdominal pain—Epirubicin—ovarian cancer	0.000581	0.00109	CcSEcCtD
Trimethadione—Feeling abnormal—Doxorubicin—ovarian cancer	0.00056	0.00105	CcSEcCtD
Trimethadione—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000556	0.00104	CcSEcCtD
Trimethadione—Abdominal pain—Doxorubicin—ovarian cancer	0.000538	0.001	CcSEcCtD
Trimethadione—Asthenia—Epirubicin—ovarian cancer	0.000527	0.000985	CcSEcCtD
Trimethadione—Pruritus—Epirubicin—ovarian cancer	0.00052	0.000971	CcSEcCtD
Trimethadione—Asthenia—Doxorubicin—ovarian cancer	0.000488	0.000912	CcSEcCtD
Trimethadione—Pruritus—Doxorubicin—ovarian cancer	0.000481	0.000899	CcSEcCtD
Trimethadione—Vomiting—Epirubicin—ovarian cancer	0.000467	0.000873	CcSEcCtD
Trimethadione—Rash—Epirubicin—ovarian cancer	0.000463	0.000866	CcSEcCtD
Trimethadione—Dermatitis—Epirubicin—ovarian cancer	0.000463	0.000865	CcSEcCtD
Trimethadione—Headache—Epirubicin—ovarian cancer	0.00046	0.00086	CcSEcCtD
Trimethadione—Nausea—Epirubicin—ovarian cancer	0.000437	0.000816	CcSEcCtD
Trimethadione—Vomiting—Doxorubicin—ovarian cancer	0.000432	0.000808	CcSEcCtD
Trimethadione—Rash—Doxorubicin—ovarian cancer	0.000429	0.000801	CcSEcCtD
Trimethadione—Dermatitis—Doxorubicin—ovarian cancer	0.000428	0.0008	CcSEcCtD
Trimethadione—Headache—Doxorubicin—ovarian cancer	0.000426	0.000796	CcSEcCtD
Trimethadione—Nausea—Doxorubicin—ovarian cancer	0.000404	0.000755	CcSEcCtD
Trimethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—BCL9—ovarian cancer	0.000131	0.0663	CbGpPWpGaD
Trimethadione—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—ovarian cancer	6.87e-05	0.0348	CbGpPWpGaD
Trimethadione—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—ovarian cancer	6.25e-05	0.0317	CbGpPWpGaD
Trimethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—SMARCA4—ovarian cancer	6.23e-05	0.0316	CbGpPWpGaD
Trimethadione—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—ovarian cancer	6.13e-05	0.0311	CbGpPWpGaD
Trimethadione—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—ovarian cancer	5.59e-05	0.0283	CbGpPWpGaD
Trimethadione—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—ovarian cancer	5.58e-05	0.0283	CbGpPWpGaD
Trimethadione—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—ovarian cancer	5.09e-05	0.0258	CbGpPWpGaD
Trimethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CCND2—ovarian cancer	4.55e-05	0.0231	CbGpPWpGaD
Trimethadione—CYP2E1—Tamoxifen metabolism—CYP1B1—ovarian cancer	3.67e-05	0.0186	CbGpPWpGaD
Trimethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—ovarian cancer	3.41e-05	0.0173	CbGpPWpGaD
Trimethadione—CACNA1G—NCAM signaling for neurite out-growth—IL6ST—ovarian cancer	3.41e-05	0.0173	CbGpPWpGaD
Trimethadione—CYP3A4—Liver X Receptor Pathway—FASN—ovarian cancer	3.39e-05	0.0172	CbGpPWpGaD
Trimethadione—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—ovarian cancer	3.36e-05	0.017	CbGpPWpGaD
Trimethadione—CYP2C8—Tamoxifen metabolism—CYP1B1—ovarian cancer	3.17e-05	0.0161	CbGpPWpGaD
Trimethadione—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ovarian cancer	3.04e-05	0.0154	CbGpPWpGaD
Trimethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—APC—ovarian cancer	2.88e-05	0.0146	CbGpPWpGaD
Trimethadione—CYP2C19—Tamoxifen metabolism—CYP1B1—ovarian cancer	2.83e-05	0.0144	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—NR5A1—ovarian cancer	2.67e-05	0.0135	CbGpPWpGaD
Trimethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—ovarian cancer	2.65e-05	0.0134	CbGpPWpGaD
Trimethadione—CYP2C9—Tamoxifen metabolism—CYP1B1—ovarian cancer	2.58e-05	0.0131	CbGpPWpGaD
Trimethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—ovarian cancer	2.55e-05	0.0129	CbGpPWpGaD
Trimethadione—CYP2C19—Melatonin metabolism and effects—CYP1B1—ovarian cancer	2.19e-05	0.0111	CbGpPWpGaD
Trimethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—ovarian cancer	2.12e-05	0.0107	CbGpPWpGaD
Trimethadione—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	2.06e-05	0.0104	CbGpPWpGaD
Trimethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—ovarian cancer	1.97e-05	0.01	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—HNF1B—ovarian cancer	1.97e-05	0.00996	CbGpPWpGaD
Trimethadione—CYP2E1—Tryptophan metabolism—CYP1B1—ovarian cancer	1.96e-05	0.00994	CbGpPWpGaD
Trimethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—ovarian cancer	1.95e-05	0.0099	CbGpPWpGaD
Trimethadione—CACNA1G—NCAM signaling for neurite out-growth—NRAS—ovarian cancer	1.93e-05	0.0098	CbGpPWpGaD
Trimethadione—CYP3A4—Estrogen metabolism—CYP1B1—ovarian cancer	1.93e-05	0.00977	CbGpPWpGaD
Trimethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—ovarian cancer	1.92e-05	0.00971	CbGpPWpGaD
Trimethadione—CACNA1G—NCAM signaling for neurite out-growth—MAPK3—ovarian cancer	1.85e-05	0.00939	CbGpPWpGaD
Trimethadione—CACNA1G—NCAM signaling for neurite out-growth—MAPK1—ovarian cancer	1.76e-05	0.00893	CbGpPWpGaD
Trimethadione—CYP3A4—Tamoxifen metabolism—CYP1B1—ovarian cancer	1.7e-05	0.00864	CbGpPWpGaD
Trimethadione—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	1.67e-05	0.00844	CbGpPWpGaD
Trimethadione—CACNA1G—NCAM signaling for neurite out-growth—KRAS—ovarian cancer	1.67e-05	0.00844	CbGpPWpGaD
Trimethadione—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	1.66e-05	0.00842	CbGpPWpGaD
Trimethadione—CYP2C8—Arachidonic acid metabolism—CYP1B1—ovarian cancer	1.59e-05	0.00804	CbGpPWpGaD
Trimethadione—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	1.59e-05	0.00804	CbGpPWpGaD
Trimethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—ovarian cancer	1.58e-05	0.00802	CbGpPWpGaD
Trimethadione—CYP2E1—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	1.56e-05	0.00793	CbGpPWpGaD
Trimethadione—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	1.52e-05	0.0077	CbGpPWpGaD
Trimethadione—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	1.45e-05	0.00733	CbGpPWpGaD
Trimethadione—CYP2C19—Arachidonic acid metabolism—CYP1B1—ovarian cancer	1.42e-05	0.00717	CbGpPWpGaD
Trimethadione—CACNA1G—NCAM signaling for neurite out-growth—HRAS—ovarian cancer	1.42e-05	0.00717	CbGpPWpGaD
Trimethadione—CYP3A4—Irinotecan Pathway—APC—ovarian cancer	1.4e-05	0.00709	CbGpPWpGaD
Trimethadione—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	1.37e-05	0.00695	CbGpPWpGaD
Trimethadione—CACNA1G—NCAM signaling for neurite out-growth—IL6—ovarian cancer	1.35e-05	0.00687	CbGpPWpGaD
Trimethadione—CYP2C8—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	1.35e-05	0.00686	CbGpPWpGaD
Trimethadione—CYP2C9—Arachidonic acid metabolism—CYP1B1—ovarian cancer	1.29e-05	0.00654	CbGpPWpGaD
Trimethadione—CYP2E1—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	1.29e-05	0.00651	CbGpPWpGaD
Trimethadione—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	1.22e-05	0.0062	CbGpPWpGaD
Trimethadione—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	1.21e-05	0.00612	CbGpPWpGaD
Trimethadione—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	1.12e-05	0.00565	CbGpPWpGaD
Trimethadione—CYP2C8—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	1.11e-05	0.00563	CbGpPWpGaD
Trimethadione—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	1.1e-05	0.00558	CbGpPWpGaD
Trimethadione—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	1e-05	0.00508	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—MET—ovarian cancer	9.98e-06	0.00506	CbGpPWpGaD
Trimethadione—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	9.92e-06	0.00503	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—IL6ST—ovarian cancer	9.77e-06	0.00495	CbGpPWpGaD
Trimethadione—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	9.54e-06	0.00484	CbGpPWpGaD
Trimethadione—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	9.1e-06	0.00461	CbGpPWpGaD
Trimethadione—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	9.04e-06	0.00458	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—MMP2—ovarian cancer	8.32e-06	0.00422	CbGpPWpGaD
Trimethadione—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	7.36e-06	0.00373	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—ERBB2—ovarian cancer	7.29e-06	0.0037	CbGpPWpGaD
Trimethadione—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	7.26e-06	0.00368	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—MET—ovarian cancer	7.12e-06	0.00361	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—IL6ST—ovarian cancer	6.98e-06	0.00354	CbGpPWpGaD
Trimethadione—CYP2E1—Biological oxidations—CYP1B1—ovarian cancer	6.83e-06	0.00346	CbGpPWpGaD
Trimethadione—CYP2E1—Metapathway biotransformation—CYP1B1—ovarian cancer	6.73e-06	0.00341	CbGpPWpGaD
Trimethadione—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—ovarian cancer	6.61e-06	0.00335	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—MMP9—ovarian cancer	6.26e-06	0.00317	CbGpPWpGaD
Trimethadione—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	5.96e-06	0.00302	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—MMP2—ovarian cancer	5.94e-06	0.00301	CbGpPWpGaD
Trimethadione—CYP2C8—Biological oxidations—CYP1B1—ovarian cancer	5.9e-06	0.00299	CbGpPWpGaD
Trimethadione—CYP2C8—Metapathway biotransformation—CYP1B1—ovarian cancer	5.82e-06	0.00295	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—VEGFA—ovarian cancer	5.62e-06	0.00285	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—NRAS—ovarian cancer	5.55e-06	0.00281	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—MAPK3—ovarian cancer	5.31e-06	0.00269	CbGpPWpGaD
Trimethadione—CYP2C19—Biological oxidations—CYP1B1—ovarian cancer	5.27e-06	0.00267	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—ERBB2—ovarian cancer	5.2e-06	0.00264	CbGpPWpGaD
Trimethadione—CYP2C19—Metapathway biotransformation—CYP1B1—ovarian cancer	5.2e-06	0.00263	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—MAPK1—ovarian cancer	5.06e-06	0.00256	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—EGFR—ovarian cancer	5.05e-06	0.00256	CbGpPWpGaD
Trimethadione—CYP2C9—Biological oxidations—CYP1B1—ovarian cancer	4.8e-06	0.00243	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—KRAS—ovarian cancer	4.78e-06	0.00242	CbGpPWpGaD
Trimethadione—CYP2C9—Metapathway biotransformation—CYP1B1—ovarian cancer	4.74e-06	0.0024	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—CTNNB1—ovarian cancer	4.55e-06	0.00231	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	4.55e-06	0.00231	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—MMP9—ovarian cancer	4.46e-06	0.00226	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—NME2—ovarian cancer	4.16e-06	0.00211	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	4.06e-06	0.00206	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—HRAS—ovarian cancer	4.06e-06	0.00206	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—VEGFA—ovarian cancer	4.01e-06	0.00203	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—STAT3—ovarian cancer	3.97e-06	0.00201	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—NRAS—ovarian cancer	3.96e-06	0.00201	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—IL6—ovarian cancer	3.88e-06	0.00197	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—MAPK3—ovarian cancer	3.79e-06	0.00192	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	3.7e-06	0.00188	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—MAPK1—ovarian cancer	3.61e-06	0.00183	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—EGFR—ovarian cancer	3.61e-06	0.00183	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—NME2—ovarian cancer	3.6e-06	0.00182	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—KRAS—ovarian cancer	3.41e-06	0.00173	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—NME2—ovarian cancer	3.21e-06	0.00163	CbGpPWpGaD
Trimethadione—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	3.17e-06	0.00161	CbGpPWpGaD
Trimethadione—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	3.12e-06	0.00158	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	3.05e-06	0.00155	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—NME2—ovarian cancer	2.93e-06	0.00148	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—HRAS—ovarian cancer	2.9e-06	0.00147	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—IL6—ovarian cancer	2.77e-06	0.0014	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2.72e-06	0.00138	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—CYTB—ovarian cancer	2.68e-06	0.00136	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—AKT1—ovarian cancer	2.56e-06	0.0013	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.49e-06	0.00126	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2.48e-06	0.00126	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—PPP1CC—ovarian cancer	2.34e-06	0.00119	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—BRIP1—ovarian cancer	2.34e-06	0.00119	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—CYTB—ovarian cancer	2.32e-06	0.00118	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.27e-06	0.00115	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.22e-06	0.00113	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—CYTB—ovarian cancer	2.07e-06	0.00105	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—BRIP1—ovarian cancer	2.03e-06	0.00103	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—PPP1CC—ovarian cancer	2.03e-06	0.00103	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.03e-06	0.00103	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.02e-06	0.00103	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—NME2—ovarian cancer	1.93e-06	0.000979	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—CYTB—ovarian cancer	1.89e-06	0.000956	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.84e-06	0.000935	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—PPP1CC—ovarian cancer	1.81e-06	0.000917	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—BRIP1—ovarian cancer	1.81e-06	0.000917	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—PPP1CC—ovarian cancer	1.65e-06	0.000836	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—BRIP1—ovarian cancer	1.65e-06	0.000836	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—YAP1—ovarian cancer	1.57e-06	0.000797	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.48e-06	0.000749	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—YAP1—ovarian cancer	1.36e-06	0.000689	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.35e-06	0.000682	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.32e-06	0.000668	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—FASN—ovarian cancer	1.28e-06	0.00065	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—SLC5A5—ovarian cancer	1.26e-06	0.000639	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—CYTB—ovarian cancer	1.24e-06	0.000631	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—SLC2A1—ovarian cancer	1.22e-06	0.000617	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—YAP1—ovarian cancer	1.21e-06	0.000615	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.2e-06	0.000609	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.2e-06	0.000609	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.18e-06	0.000599	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—CYP1B1—ovarian cancer	1.17e-06	0.000592	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—FASN—ovarian cancer	1.11e-06	0.000562	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—YAP1—ovarian cancer	1.11e-06	0.000561	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.09e-06	0.000555	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—SLC5A5—ovarian cancer	1.09e-06	0.000552	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.09e-06	0.000551	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.09e-06	0.000551	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.06e-06	0.000535	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—SLC2A1—ovarian cancer	1.05e-06	0.000534	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	1.04e-06	0.000525	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.03e-06	0.000522	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—CYP1B1—ovarian cancer	1.01e-06	0.000512	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—FASN—ovarian cancer	9.89e-07	0.000501	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—SLC5A5—ovarian cancer	9.73e-07	0.000493	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	9.63e-07	0.000488	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—ABCB1—ovarian cancer	9.62e-07	0.000487	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—TYMS—ovarian cancer	9.44e-07	0.000479	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—SLC2A1—ovarian cancer	9.4e-07	0.000476	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	9.2e-07	0.000466	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—FASN—ovarian cancer	9.02e-07	0.000457	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—CYP1B1—ovarian cancer	9.01e-07	0.000457	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	8.95e-07	0.000454	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	8.91e-07	0.000451	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—SLC5A5—ovarian cancer	8.87e-07	0.00045	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—SLC2A1—ovarian cancer	8.57e-07	0.000434	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.39e-07	0.000425	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—ABCB1—ovarian cancer	8.31e-07	0.000421	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—CYP1B1—ovarian cancer	8.21e-07	0.000416	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—TYMS—ovarian cancer	8.16e-07	0.000414	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	7.99e-07	0.000405	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.95e-07	0.000403	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—CAV1—ovarian cancer	7.61e-07	0.000386	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—ABCB1—ovarian cancer	7.42e-07	0.000376	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—YAP1—ovarian cancer	7.3e-07	0.00037	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—TYMS—ovarian cancer	7.29e-07	0.000369	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	7.29e-07	0.000369	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.25e-07	0.000367	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—PIK3CG—ovarian cancer	6.93e-07	0.000351	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—ABCB1—ovarian cancer	6.76e-07	0.000343	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—TYMS—ovarian cancer	6.64e-07	0.000337	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—CAV1—ovarian cancer	6.58e-07	0.000333	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.28e-07	0.000319	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—PIK3CD—ovarian cancer	6.09e-07	0.000309	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—PIK3CG—ovarian cancer	5.99e-07	0.000304	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—FASN—ovarian cancer	5.95e-07	0.000301	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—CAV1—ovarian cancer	5.87e-07	0.000298	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—SLC5A5—ovarian cancer	5.85e-07	0.000297	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—SLC2A1—ovarian cancer	5.65e-07	0.000286	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.61e-07	0.000284	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—CYP1B1—ovarian cancer	5.42e-07	0.000275	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—CAV1—ovarian cancer	5.35e-07	0.000271	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—PIK3CG—ovarian cancer	5.35e-07	0.000271	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—PIK3CB—ovarian cancer	5.31e-07	0.000269	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—PIK3CD—ovarian cancer	5.27e-07	0.000267	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.11e-07	0.000259	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—PIK3CG—ovarian cancer	4.88e-07	0.000247	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	4.8e-07	0.000244	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—PIK3CD—ovarian cancer	4.7e-07	0.000238	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—PIK3CB—ovarian cancer	4.59e-07	0.000233	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—PTEN—ovarian cancer	4.59e-07	0.000233	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—ABCB1—ovarian cancer	4.46e-07	0.000226	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—TYMS—ovarian cancer	4.38e-07	0.000222	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—PIK3CD—ovarian cancer	4.29e-07	0.000217	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—PIK3CB—ovarian cancer	4.1e-07	0.000208	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—PTEN—ovarian cancer	3.97e-07	0.000201	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—PIK3CB—ovarian cancer	3.74e-07	0.000189	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—PTEN—ovarian cancer	3.54e-07	0.000179	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—CAV1—ovarian cancer	3.53e-07	0.000179	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—PIK3CA—ovarian cancer	3.24e-07	0.000164	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—PTEN—ovarian cancer	3.23e-07	0.000164	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—PIK3CG—ovarian cancer	3.22e-07	0.000163	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.83e-07	0.000143	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—PIK3CA—ovarian cancer	2.8e-07	0.000142	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—AKT1—ovarian cancer	2.65e-07	0.000134	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—PIK3CA—ovarian cancer	2.5e-07	0.000127	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.46e-07	0.000125	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—AKT1—ovarian cancer	2.29e-07	0.000116	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—PIK3CA—ovarian cancer	2.28e-07	0.000115	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—PTEN—ovarian cancer	2.13e-07	0.000108	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—AKT1—ovarian cancer	2.04e-07	0.000103	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—AKT1—ovarian cancer	1.86e-07	9.43e-05	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.5e-07	7.61e-05	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—AKT1—ovarian cancer	1.23e-07	6.22e-05	CbGpPWpGaD
